Cargando…
PPAR Agonists and Cardiovascular Disease in Diabetes
Peroxisome proliferators activated receptors (PPARs) are ligand-activated nuclear transcription factors that play important roles in lipid and glucose homeostasis. To the extent that PPAR agonists improve diabetic dyslipidaemia and insulin resistance, these agents have been considered to reduce card...
Autores principales: | Calkin, Anna C., Thomas, Merlin C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2233765/ https://www.ncbi.nlm.nih.gov/pubmed/18288280 http://dx.doi.org/10.1155/2008/245410 |
Ejemplares similares
-
Should We Use PPAR Agonists to Reduce Cardiovascular Risk?
por: Robinson, Jennifer G.
Publicado: (2008) -
PPARα Agonist Oral Therapy in Diabetic Retinopathy
por: Tomita, Yohei, et al.
Publicado: (2020) -
New Insights into the PPARγ Agonists for the Treatment of Diabetic Nephropathy
por: Jia, Zhanjun, et al.
Publicado: (2014) -
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases
por: Khuchua, Zaza, et al.
Publicado: (2018) -
PPAR Agonists for the Prevention and Treatment of Lung Cancer
por: Lakshmi, Sowmya P., et al.
Publicado: (2017)